In this interactive expert meeting, the current immunotherapy treatment landscape and future perspectives in NSCLC were explained, how to optimize the treatment of immune-related side effects and relevant patient cases were discussed.

Agenda:

• Evolving Treatment landscape in First-Line Treatment for NSCLC - Prof. Martin Reck (Lung Clinic Grosshansdorf, Germany)
• How to optimize the management of immune-related side effects - Prof. Michael Thomas (Thoraxklinik Heidelberg, Germany)
• Future prospects of immune therapeutic strategies and biomarkers - Prof. Inge Marie Svane (Centre for Cancer Immune Therapy, Copenhagen University Hospital, Denmark)